Up-regulating the expression of CCL19 in tumors can inhibit its growth by effectively recruiting CCR7 + DC and IFN-γ + CD8 + T cells into tumor locations, which can be a powerful anti-tumor treatment combined with anti-PDL150. This evidence concerns the gene CCL19 and neoplasm.